Why a Kyphon could NEVER happen today.

Kyphon was an amazing disruptive exponential growth spine company. Just try to wrap your head around the Kyphon sales trajectory (never to be seen again).

1996 – First funding 2000 – $6M sales 1998 – FDA approves balloon kyphoplasty, but not the bone cement filler. 2001 – $36M sales 2002 – $76M sales (IPO) 2003 – $131M sales 2004 – $306M sales (*FDA approves use of tamp with cement in the spine without any clinical data.) 2005 – $408M sales 2007 – acquired for $4.2B by Medtronic

Fast forward to startups today and we just don't see companies taking moonshots like the startups in the 1990s. S...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top